186328 RESULTS

Preclinical Research Offers New Angles on Immunotherapy

CONFERENCE COVERAGE 2015-11-27 Conference Coverage Despite early disappointments, drug developers have bought into immunotherapy for Alzheimer’s disease, banking on a handful of antibodies and active vaccines currently in Phase 2/3 trials and others in Phase 1. As evident from this ...

Health Interventions Boost Cognition—But Do They Delay Dementia?

CONFERENCE COVERAGE 2015-11-27 Conference Coverage It has become a mantra in the Alzheimer’s field that staying active—physically, cognitively, and socially—can protect the brain against decline. But can this be turned into a viable intervention? At the 8th Clinical Trials in Alzheimer ...

Current Filters

No filters selected

Filter By

  • All
  • Past 7 Days
  • Past 30 Days
  • Past 90 Days
  • Past 12 Months
  • Specific Dates
    1. From